83 related articles for article (PubMed ID: 11244307)
1. Significance of salivary epidermal growth factor in peptic ulcer disease in hemodialysis patients.
Guh JY; Chen HC; Chuang LY; Yang CY; Tsai JH; Lai YH
Nephron; 2001 Feb; 87(2):134-8. PubMed ID: 11244307
[TBL] [Abstract][Full Text] [Related]
2. Salivary immunoreactive human epidermal growth factor (IR-hEGF) in patients with peptic ulcer disease.
Ohmura E; Emoto N; Tsushima T; Watanabe S; Takeuchi T; Kawamura M; Shigemoto M; Shizume K
Hepatogastroenterology; 1987 Aug; 34(4):160-3. PubMed ID: 3499370
[TBL] [Abstract][Full Text] [Related]
3. Salivary epidermal growth factor in patients with and without acid peptic disease.
Maccini DM; Veit BC
Am J Gastroenterol; 1990 Sep; 85(9):1102-4. PubMed ID: 2389722
[TBL] [Abstract][Full Text] [Related]
4. [Salivary epidermal growth factor in patients with peptic ulcer].
Hirasawa Y; Asaki S; Hongo M; Ohara S; Shibuya D; Yamaguchi N; Matsuda K; Toyota T
Nihon Shokakibyo Gakkai Zasshi; 1991 Apr; 88(4):1043-50. PubMed ID: 1856997
[TBL] [Abstract][Full Text] [Related]
5. Salivary and gastric epidermal growth factor in patients with Zollinger-Ellison syndrome: its protective potential.
Sarosiek J; Jensen RT; Maton PN; Peura DA; Harlow D; Feng T; McCallum RW; Pisegna JR
Am J Gastroenterol; 2000 May; 95(5):1158-65. PubMed ID: 10811321
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of peptic ulcer disease in connective tissue disease patients associated with xerostomia.
Luo JC; Lin HY; Chang FY; Lu RH; Lu CL; Chen CY; Lee SD
Aliment Pharmacol Ther; 2003 Jan; 17(2):217-24. PubMed ID: 12534406
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor in saliva and gastric juice: response to histamine.
Tunio AM; Hobsley M
Gut; 1995 Sep; 37(3):335-9. PubMed ID: 7590427
[TBL] [Abstract][Full Text] [Related]
8. Kinetics of epidermal growth factor in saliva.
Ino M; Ushiro K; Ino C; Yamashita T; Kumazawa T
Acta Otolaryngol Suppl; 1993; 500():126-30. PubMed ID: 8452009
[TBL] [Abstract][Full Text] [Related]
9. Salivary and gastric luminal release of epidermal growth factor under basal conditions and after pentagastrin stimulation in healthy subjects and in duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek PC; Ernst H; Konturek J; Bobrzyński A; Kwiecień N; Faller G; Gedliczka O; Hahn EG
J Physiol Pharmacol; 1996 Mar; 47(1):187-94. PubMed ID: 8777298
[TBL] [Abstract][Full Text] [Related]
10. Gastric juice immunoreactive epidermal growth factor levels in patients with peptic ulcer disease.
Calabrò A; Orsini B; Brocchi A; Falchini M; Fedi P; Surrenti C
Am J Gastroenterol; 1990 Apr; 85(4):404-7. PubMed ID: 2327382
[TBL] [Abstract][Full Text] [Related]
11. Salivary concentration of epidermal growth factor in adults with reflux laryngitis before and after treatment.
Eckley CA; Sardinha LR; Rizzo LV
Ann Otol Rhinol Laryngol; 2013 Jul; 122(7):440-4. PubMed ID: 23951695
[TBL] [Abstract][Full Text] [Related]
12. EGF in saliva and tumor samples of oral squamous cell carcinoma.
Bernardes VF; Gleber-Netto FO; Sousa SF; Silva TA; Abreu MH; Aguiar MC
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):528-33. PubMed ID: 21436680
[TBL] [Abstract][Full Text] [Related]
13. [Changes of epidermal growth factor level in blood serum, saliva and gastric juice in children with duodenal ulcer].
Zhukova EA; Vidmanova TA; Viskova IN; Kolesov SA; Korkotashvili LV; Shirokova NIu; Kan'kova NIu
Vestn Ross Akad Med Nauk; 2013; (12):36-40. PubMed ID: 24741940
[TBL] [Abstract][Full Text] [Related]
14. [Salivary epidermal growth factor (EGF) in Sjögren's syndrome: association between salivary EGF levels and the severity of intraoral manifestations].
Azuma N; Katada Y; Kitano S; Nishioka A; Sekiguchi M; Kitano M; Hashimoto N; Matsui K; Iwasaki T; Sano H
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(1):42-50. PubMed ID: 27181234
[TBL] [Abstract][Full Text] [Related]
15. Giant peptic ulcers in patients undergoing maintenance hemodialysis.
Troskot B; Kes P; Duvnjak M; Ratković-Gusić I; Supanc V
Acta Med Croatica; 1995; 49(2):59-64. PubMed ID: 7580040
[TBL] [Abstract][Full Text] [Related]
16. Is salivary epidermal growth factor a biomarker for oral leukoplakia? A preliminary study.
Jaeger F; Assunção AC; Caldeira PC; Queiroz-Junior CM; Bernardes VF; de Aguiar MC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Apr; 119(4):451-8. PubMed ID: 25701553
[TBL] [Abstract][Full Text] [Related]
17. Secretion of epidermal growth factor in saliva of duodenal ulcer patients; an association with Helicobacter pylori eradication and erosive esophagitis.
Kiluk A; Namiot DB; Namiot Z; Leszczyńska K; Kurylonek AJ; Kemona A
Adv Med Sci; 2008; 53(2):305-9. PubMed ID: 18930874
[TBL] [Abstract][Full Text] [Related]
18. The secretory characteristics of epidermal growth factor in human saliva.
McGurk M; Hanford L; Justice S; Metcalfe RA
Arch Oral Biol; 1990; 35(8):653-9. PubMed ID: 2256820
[TBL] [Abstract][Full Text] [Related]
19. Distribution and release of epidermal growth factor in man.
Konturek JW; Bielanski W; Konturek SJ; Bogdal J; Oleksy J
Gut; 1989 Sep; 30(9):1194-200. PubMed ID: 2806986
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor in gastric ulcer healing by nocloprost, a stable prostaglandin E2 derivative.
Konturek JW; Hengst K; Konturek SJ; Domschke W
Scand J Gastroenterol; 1997 Oct; 32(10):980-4. PubMed ID: 9361169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
